Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
What makes a behavioral health pro forma defensible to institutional capital
Investors trust a behavioral health pro forma when the operator ties every revenue and cost line to a defensible operational input: licensed bed count, ASAM Criteria Fourth Edition level of care, payer mix by contract status, credentialed clinician ratios, and a ramp curve that reflects real licensure and credentialing gating events. Founder optimism is not a benchmark. Third-party data is.
When my team at Atlantic Health Strategies rebuilds a model for a PE-backed buyer or an SBA 7(a) lender, we throw out anything that starts with an aspirational census and works backward. We start with the survey window, the accreditation timeline, and the payer credentialing calendar, then let revenue follow the operational reality. That is the sequence sophisticated buyers stress-test first.
Recent market data reinforces why the model has to hold up. Mertz Taggart’s Q4 2025 Behavioral Health M&A Report counted 180 total behavioral health transactions in 2025, slightly up from 176 in 2024, and noted that deal timelines lengthened as lenders conducted “forensic” diligence on insurance receivables and cash collections. Buyers are reading your AR aging schedule with a magnifying glass. Your pro forma needs to survive that read.
Revenue assumptions: ASAM level, payer mix, and the credentialing cash gap
The revenue side of the model breaks first when operators guess at per diem rates without anchoring to the ASAM Fourth Edition level of care they are actually licensed to deliver. A Level 3.5 clinically managed high-intensity residential program does not bill like a Level 3.7 residential withdrawal management program, and neither bills like a Level 2.5 partial hospitalization program (which, worth repeating, is an outpatient level of care). If the model uses one blended per diem across mixed acuity, sophisticated buyers will discount the whole thing.
Payer mix has to be built contract by contract, not “70% commercial / 30% self-pay” on a single line. Institutional investors want to see in-network contracts by payer, single case agreement (SCA) rates for out-of-network episodes, verification of benefits (VOB) conversion assumptions, and utilization management denial exposure. The commercial versus Medicaid spread is real and material: KFF’s behavioral health workforce analysis notes that only 36% of psychiatrists accept new Medicaid patients, lower compared to other payers and compared to rates for physicians overall (71%), a datapoint that tells you exactly why Medicaid-heavy models get discounted on multiple.
Then there is the credentialing cash gap. NPI issuance, CAQH attestation, and payer-by-payer credentialing regularly run 90 to 180 days per commercial payer, and first claim adjudication adds another 30 to 60 days. For a 40-bed Level 3.5 program modeling a $950 blended per diem, that is roughly $1.14M of commercial revenue per month sitting behind the credentialing wall. A pro forma that shows collections in month two is a pro forma that will not close. Model the gap. Fund the gap. Show the reserve.
Length of stay assumptions also need to reflect the federal data. SAMHSA’s TEDS 2021 report shows short-term residential and long-term residential LOS distributions that most first-time operators overestimate; the historical TEDS discharge data showed median LOS for treatment completers in short-term residential treatment was 27 days. If your model assumes a 45-day average LOS with a full commercial book, expect diligence to cut it.
Cost structure: clinical FTEs, ramp curves, and the regulatory gating calendar
Cost lines fail diligence when operators build them as a percentage of revenue instead of as an absolute staffing model driven by ASAM staffing ratios and state licensure minimums. A 40-bed Level 3.5 residential program in Florida (regulated by AHCA and DCF) does not staff like a 40-bed program in Virginia (regulated by DBHDS), and neither staffs like a Massachusetts BSAS-licensed facility or a New Jersey DMHAS-licensed one. State minimums drive nurse, tech, therapist, and medical director hours. Build the schedule, then price the schedule.
Ramp to stabilized census is the second cost trap. The gating events are non-negotiable and sequential: state licensure survey, initial Joint Commission (TJC) or CARF survey (typically 6 to 12 months post-opening because both bodies require a track record of admissions before initial accreditation), payer credentialing completion, and then in-network claim adjudication. Investors want to see 9 to 15 months of ramp modeled, with fixed cost carry, before stabilized census. For that same 40-bed program, fixed monthly operating cost through ramp routinely runs $350K to $500K before meaningful commercial collections. Anyone showing 90-day ramp to 85% occupancy is telling the diligence team they have never opened a facility.
Workforce cost inflation is a real line. KFF workforce analysis found that nearly half the U.S. Population, 47%, or 158 million people, live in a mental health workforce shortage area. If your facility sits in a HRSA-designated HPSA, your wage assumptions need a premium, not a discount. In tight labor markets we routinely see BHT wages 15 to 25% above the modeled Bureau of Labor Statistics median, and LCSW/LMHC comp running $85K to $105K where the founder penciled in $70K.
The valuation lens: EBITDA multiples, denial rates, and the red flags PE diligence surfaces
Operators build pro formas to raise capital or to sell. Either way, the model needs to reconcile to how the buyer will value the business. Current market benchmarks vary sharply by segment and network status. According to MA Healthcare Advisors’ 2025 review, out-of-network SUD providers generally see multiples between 4X and 6X. In-network SUD and mental health providers can command higher multiples, often above 6X if they demonstrate strong operational efficiency. Platform-scale assets clear higher: FOCUS Investment Banking reported that platforms with clinical quality programs, low cancellation rates, and centralized intake systems routinely trade at 12–15×.
The arbitrage is why buyers scrutinize the model so hard. As one industry tracker summarizing the FOCUS data put it, “The arbitrage gap, 4 to 6 times acquired into 10 to 13 times platform, is the explicit roll-up thesis”. On a $3M EBITDA asset, that spread is the difference between a $15M exit and a $39M exit. If your pro forma cannot survive quality-of-earnings diligence, you will not clear the platform threshold and you will sell at the low end of the tuck-in band.
Red flags PE diligence teams surface in first-time operator pro formas, in the order I see them:
- Blended per diem across ASAM levels without a rate table by payer and contract status.
- Denial rate assumptions under 5% for a startup residential or PHP program. Behavioral health denial and takeback rates run materially higher, and industry RCM benchmarks from HFMA and MGMA consistently show behavioral health outside the norms of general medical, with first-pass denial rates commonly 12 to 18% at startup.
- Days in AR under 45 for a facility that is not yet in-network with its top three payers. Realistic startup DAR sits at 65 to 90.
- No line for utilization review labor or concurrent review denials, which for out-of-network programs can shave 15 to 30% off billed revenue.
- No MHPAEA-related contingency. Mental Health Parity and Addiction Equity Act enforcement, and the recent parity rollback conversation, changes payer behavior in ways every model should stress.
- No regulatory gating calendar mapping licensure survey, TJC or CARF initial survey, CMS Conditions of Participation compliance (for facilities pursuing IPF PPS), and 42 CFR Part 2 program stand-up to revenue milestones.
The Mertz Taggart Q4 2025 commentary summed up the current environment cleanly: “Premium assets with strong outcomes and management still command high multiples, while distressed situations are increasingly common”. Your pro forma is the first artifact that tells a buyer which side of that line you are on.
Frequently asked questions
How many months of ramp should I model before hitting stabilized census?
For a residential SUD or Level 3.5 program, model 9 to 15 months to stabilized census with full fixed cost carry from month one. The gating events (state licensure, TJC or CARF initial survey, payer credentialing completion, first claim adjudication) run sequentially and cannot be compressed by capital. For a PHP/IOP program with faster licensure and no accreditation prerequisite, 6 to 9 months is more realistic, but still not the 90 days most first-time founders assume.
What payer mix assumptions do institutional investors consider realistic for a new SUD residential program?
Buyers want to see mix broken out by payer and by contract status (in-network, out-of-network with SCA, self-pay). A model showing 100% commercial in-network at rack rate in year one is not credible. A defensible year-one mix reflects that most commercial payers will still be in credentialing for the first 6 to 9 months, so revenue in that window comes from SCAs, cash-pay, and any Medicaid contract already in hand.
How do I model the cash gap created by payer credentialing and first-claim adjudication?
Build a separate cash-flow schedule that assumes zero commercial collections for the first 90 to 180 days per payer, layer in a 30 to 60 day first-claim adjudication lag, and then apply a realistic denial and takeback assumption on top. For most 40-to-60-bed residential builds we see, that gap ranges $2M to $4M in working capital. Fund it with equity, an SBA 7(a) or 504 facility sized to the working capital need, or a bridge line. Show the reserve on the balance sheet in the model. Investors read this before they read revenue.
What EBITDA margin range is defensible for a Level 3.5 residential program versus a PHP/IOP?
Stabilized Level 3.5 residential programs with a healthy commercial mix generally underwrite to 18 to 25% EBITDA margins; PHP/IOP outpatient can run higher (25 to 35%) at scale because of lower fixed cost per census point. Anyone modeling 40%+ margins in year two is either running a very specific out-of-network arbitrage that PE will discount hard, or building a model diligence will not clear.
Which line items do sophisticated investors immediately flag as unrealistic in first-time operator pro formas?
Blended per diems, ramp curves under 6 months, denial rates under 5%, days in AR under 45, no utilization review staffing, no regulatory gating calendar, no reserve for the credentialing cash gap, and workforce cost assumptions that ignore the HRSA HPSA reality of the facility’s actual location. Fix these before the model leaves your finance team.
References
- Mertz Taggart, Q4 2025 Behavioral Health M&A Report
- FOCUS Investment Banking, Behavioral Health EBITDA Multiples 2025 Update
- MA Healthcare Advisors, Behavioral M&A Trends: Insights on 2025 Market Shifts
- KFF, Strategies to Address Behavioral Health Workforce Shortages: State Medicaid Programs
- KFF, Medicaid Mental Health and Substance Use: Expansion Trends and Fiscal Pressure
- SAMHSA, Treatment Episode Data Set (TEDS) 2021 Annual Report
- SAMHSA, TEDS 2011 Discharge Report
- Healthcare Finance News, KFF analysis on Medicaid behavioral health workforce